How many insider declarations has Holdbrook Mark J. filed?

Holdbrook Mark J. has filed 2 public insider declarations with SEC (Form 4).

What is Holdbrook Mark J.'s role?

Holdbrook Mark J.'s reported role is not specified by the regulator across the filings.

Which companies does Holdbrook Mark J. report trades for?

Holdbrook Mark J. reports trades for Tarsus Pharmaceuticals, Inc..

What is Holdbrook Mark J.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 2k€.

← Executives ★ Sign in to follow

HM

Holdbrook Mark J.

·SEC (Form 4)

Tarsus Pharmaceuticals, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€2,352

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Holdbrook Mark J.. Insider active across 1 company, notably Tarsus Pharmaceuticals, Inc.. Aggregated, 2 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €2k. History available since 17 March 2023. The latest transaction was filed on 17 March 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to Holdbrook Mark J.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Tarsus Pharmaceuticals, Inc. (US)

申报2 总计

▼

Holdbrook Mark J.

V.P., Clinical Affairs高管2023年3月17日Tarsus Pharmaceuticals, Inc.

US$2,49737SEC ↗

188 股@ US$13.28100.0% 占其流量Common StockSEC:0001827564-23-000002:0

◇

Holdbrook Mark J.

V.P., Clinical Affairs高管2023年3月15日Tarsus Pharmaceuticals, Inc.

0SEC ↗

2,653 股Common StockSEC:0001209191-23-019885:0

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

HM

Holdbrook Mark J.

·SEC (Form 4)

Tarsus Pharmaceuticals, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€2,352

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Holdbrook Mark J.. Insider active across 1 company, notably Tarsus Pharmaceuticals, Inc.. Aggregated, 2 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €2k. History available since 17 March 2023. The latest transaction was filed on 17 March 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.